Evolution of the SARS-CoV-2 omicron variants BA.1 to BA.5: Implications for immune escape and transmission.

Shrestha, Lok Bahadur; Foster, Charles; Rawlinson, William; Tedla, Nicodemus; Bull, Rowena A

Shrestha, Lok Bahadur; Foster, Charles; Rawlinson, William; Tedla, Nicodemus; Bull, Rowena A.

Afiliação

Shrestha LB; School of Medical Sciences, Faculty of Medicine, UNSW, Sydney, New South Wales, Australia.
Foster C; The Kirby Institute, UNSW, Sydney, New South Wales, Australia.
Rawlinson W; School of Medical Sciences, Faculty of Medicine, UNSW, Sydney, New South Wales, Australia.
Tedla N; Serology and Virology Division, Department of Microbiology, New South Wales Health Pathology, Sydney, New South Wales, Australia.
Bull RA; School of Medical Sciences, Faculty of Medicine, UNSW, Sydney, New South Wales, Australia.

Rev Med Virol ; 32(5): e2381, 2022 09.

Article em En | MEDLINE | ID: mdl-35856385

Assuntos

COVID-19; SARS-CoV-2; Anticorpos Monoclonais/uso terapêutico; Anticorpos Monoclonais Humanizados; Anticorpos Neutralizantes; Anticorpos Antivirais; Humanos; SARS-CoV-2/genética

Palavras-chave

SARS-COV-2; immune evasion; monoclonal antibodies; omicron

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: SARS-CoV-2 / COVID-19 Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google